The lack of statistical significance in SUVmax for evaluating HER2 expression in gastric cancer may be attributed to the complex regulation of metabolic activity in HER2-positive tumors by molecular subtypes, histological classifications, and co-expressed molecular pathways. This evidence concerns the gene ERBB2 and gastric cancer.